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Generation of reactive oxygen species by damaged respiratory chain followed by the formation of
cytochrome c (cyt c)–cardiolipin (CL) complex with peroxidase activity are early events in apoptosis.
By quenching the peroxidase activity of cyt c–CL complexes in mitochondria, nitric oxide can exert
anti-apoptotic effects. Therefore, mitochondria-targeted pro-drugs capable of gradual nitric oxide
radical (NO) release are promising radioprotectants. Here we demonstrate that (2-hydroxyamino-
vinyl)-triphenyl-phosphonium effectively accumulates in mitochondria, releases NO upon mito-
chondrial peroxidase reaction, protects mouse embryonic cells from irradiation-induced apoptosis
and increases their clonogenic survival after irradiation. We conclude that mitochondria-targeted
peroxidase-activatable NO-donors represent a new interesting class of radioprotectors.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction attractive targets for the discovery of drugs with radioprotectiveGamma irradiation-induced injury of cells involves nuclear DNA
damage which – if not repaired – is followed by mitochondria-
dependent apoptosis [1]. Generation of reactive oxygen species
(ROS) by disrupted electron transport, subsequent cardiolipin
(CL) oxidation and formation of permeability transition pore are
important mitochondrial stages of apoptotic program. Because
these events precede the release of pro-apoptotic factors from
mitochondria into the cytosol, caspase activation and progression
of apoptosis beyond the ‘‘point-of-no-return”, they representchemical Societies. Published by E
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Recently, a novel approach based on mitochondrial targeting of
bioactive molecules has been developed that includes conjugation
of small molecular payloads with vehicles displaying high afﬁnity
to mitochondria or their constituents (reviewed in [2–4]). The ma-
jor targeting strategies include employment of vehicle-molecules
that accumulate in mitochondria due to their: (i) high afﬁnity
binding to one or more of intra-mitochondrial sites, (ii) hydropho-
bicity and positive charge, (iii) ability to enter mitochondria via
carrier proteins unique to the organelle, and (iv) speciﬁc metabo-
lism by mitochondrial enzymes. In our previous work, we realized
the ﬁrst principle (i) and demonstrated that an electron scavenger,
nitroxide radical, conjugated with a segment of an antibiotic,
gramicidin S, selectively partitioned into mitochondria, prevented
superoxide production and CL oxidation protected cells against
apoptosis induced by actinomycin D [5] or irradiation [6].
Another commonly employed protocol – conjugation with a
hydrophobic cation, triphenyl-phosphonium (TP) – utilizes
‘‘electrophoresis” of the vehicle and cargo into mitochondria at
the expense of negative inside membrane potential [7] Welsevier B.V. All rights reserved.
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mino-vinyl)-triphenyl-phosphonium (HVTP) and demonstrated
that HVTP effectively integrates into cells, selectively partitions
into mitochondria, and releases nitric oxide radical (NO) upon oxi-
dation by cytochrome c (cyt c)/CL complexes with peroxidase
activity. We further showed that the production of NO by HVTP
was associated with the reduction of reactive oxo-ferryl intermedi-
ates and inhibition of peroxidase activity of the cyt c/CL complex
[8]. Because cyt c catalyzed CL peroxidation has been identiﬁed
as an essential step in radiation induced apoptosis [6,9] we rea-
soned that HVTP may exert properties of a radioprotector by inhib-
iting the mitochondrial peroxidase functions of cyt c/CL complex.
In the current work, we report effective accumulation of HVTP in
mitochondria of mouse embryonic cells (MECs) and its protection
against irradiation-induced apoptosis as evidenced by inhibition
of cyt c release, caspase activation and phosphatidylserine (PS)
externalization. Colony-formation assay demonstrated marked
protective effects of HVTP against radiation injury of cells.2. Materials and methods
2.1. Reagents
Horse heart cyt c (type C-7752), diethylenetriaminepentaacetic
acid (DTPA), hydrogen peroxide and tert-butyl hydroperoxide (tBu-
OOH) were purchased from Sigma–Aldrich (St. Louis, MO). 1,1,2,2-
Tetraoleoyl cardiolipin (TOCL) and dioleoyl-L-phosphatidylcholine
(PC) were obtained from Avanti Polar Lipids Inc. (Albaster, AL).
Dihydroethdium (DHE) and 5,50,6,60-tetrachloro-1,10,3,30-tetraeth-
ylbenzimidazolylcarbocyanine iodide (JC-1) were purchased from
Invitrogen (Carlsbad, CA). N-Acetyl-Asp-Glu-Val-Asp-AMC (7-ami-
no-4-methylcoumarin, DEVD–AMC) was purchased from BioMol
International Inc. (Plymouth Meeting, PA). Mouse anti-cyt c anti-
body (clone 7H8.2C12) was obtained from BD Biosciences (Franklin
Lakes, NJ); goat anti-mouse HRP-conjugated antiserum was pur-
chased from Pierce (Rockford, IL). Annexin-V detection kit was pur-
chased from BioVision (Mountain View, CA). Diethylamine
NONOate (DEANONOate) was purchased from Cayman Chemicals
(Ann Arbor, MI).
2.2. Cell culture
Mouse embryonic cells (courtesy of Dr. X. Wang, University of
Texas, Dallas [10]) were cultured in Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) supplemented with 15% fetal bovine serum,
25 mM of HEPES (4(2-hydroxyethyl)-1-piperazineethane-sulfonic
acid), 50 mg/l of uridine, 110 mg/l of pyruvate, 2 mM of glutamine,
1 non-essential amino acids, 0.05 mM of 20-mercaptoethanol,
0.5  106 U/l of mouse leukemia inhibitory factor, 100 U/l of peni-
cillin, and 100 lg/l of streptomycin in a humidiﬁed atmosphere of
5% carbon dioxide:95% air at 37 C.
2.3. Isolation of mitochondria
Cells (1  106) were seeded in 100 mm cell culture dishes and
let attached overnight. Cells were incubated with HVTP (100 lM;
1–4 h) then collected by trypsinization and washed twice with
PBS. Mitochondria fraction was isolated by differential centrifuga-
tion as described in [8].
2.4. NO production
Production of NO in vitro and in isolated mitochondria (50 lg
per sample) was measured with ﬂuorescent probe diaminonaph-
thalene conjugated with TP cation (mitoDAN, Fig. 1C, insert). Quan-tiﬁcation of NO was performed with the NO-donor diethylamine
NONOate (DEANONOate, half-life at 25 C, 2 min), which releases
1.5 mol NO per mol of parent compound [11]. Fluorescence was
measured on 5301 PC spectroﬂuorimeter (Shimadzu, Japan) on
0–60 min (kex = 375 nm; slits 10 nm).
2.5. Preparation of liposomes and nitration of cyt c in vitro
Liposomes containing dioleoyl-phosphatidylcholine (PC) and
tetraoleoyl CL (TOCL) (TOCL/PC ratio 1:1), were prepared in
50 mM phosphate buffer (pH 7.4) by sonication under N2 and used
immediately after preparation. To prevent redox cycling with free
metals diethylenetriaminepenta-acetic acid (DTPA) (100 lM) was
added to all solutions used. Cyt c (200 lM) was incubated with
TOCL/PC liposomes (4 mM total lipids, 1:1 CL:PC ratio) for
10 min. Then, 2.5–12.5 mM HVTP was added and the reaction mix-
ture was incubated with 5–50 mM H2O2 for 15 min. After termina-
tion of the reaction with catalase (ﬁnal activity 0.1 U/ml), equal
amounts of protein (3 nmol) were resolved by SDS–PAGE (15%)
and transferred onto a nitrocellulose membrane. The membrane
was blocked in Super Block blocking buffer in TBST (Pierce) at RT
for 1 h, incubated with anti-nitrotyrosine antibody (1:2000 dilu-
tion, Upstate) overnight in a 10-fold diluted Super Block solution,
washed ﬁve times in TBST, and then incubated with alkaline phos-
phatase-conjugated goat anti-mouse antibody for 60 min at RT.
The protein bands were visualized by ECF Substrate (Amersham)
and a Typhoon Scanner.
2.6. High performance liquid chromatography (HPLC) analysis of HVTP
Detection of HVTP was performed with a SPD-M10Avp photodi-
ode array detector (Shimadzu, Kyoto, Japan) as described earlier
[8].
2.7. Irradiation
Cells were pre-incubated with HPTV in complete culture med-
ium for 1–6 h and then were c-irradiated using a Shepherd model
143-45A irradiator (J.L. Shepherd and Associates, San Fernando,
CA) at a dose-rate of 4 Gy/min. HVTP containing medium were re-
placed with fresh culture medium right after irradiation. Cells were
then incubated at 37 C in 5% carbon dioxide:95% air until harvest.
2.8. Accumulation of cyt c in cytosol
Translocation of cyt c was examined by using Western blot [6].
Densitometry of Western blot-stained protein bands on gels was
performed by using Scion-Image software (http://www.scion-
corp.com) and normalized to the amount of b-actin.
2.9. Caspase activity
Caspase-3/7 activity in cell lysates was measured with a DEVD–
AMC substrate. Brieﬂy, cell homogenates (10 lg protein) were
incubated with 20 lMDEVD–AMC and ﬂuorescence was measured
with a Fusion plate reader (excitation ﬁlter 390/15 nm, emission
ﬁlter 460/35 nm) after 1 h incubation.
2.10. Superoxide generation
Oxidation-dependent ﬂuorogenic dye DHE was used to evaluate
intracellular production of superoxide radicals as described earlier
[6]. Mitochondrial production of superoxide was evaluated by Mit-
oSOX Red assay. Brieﬂy, MECs (0.05  106) were seeded in 35 mm
cell culture dishes and let attached overnight. Then cells were pre-
incubated with HVTP (100 lM) for 4 h, irradiated (10 Gy), washed
Fig. 1. Integration and bioactivation of HVTP in mitochondria. (A) Typical chromatogram of HVTP in mitochondrial fraction. Insert – absorbance spectrum of HVTP. (B) Time
course of HVTP accumulation in mitochondria after its incubation over 0–4 h; after washing away exogenous HVTP (at 4 h), its content in mitochondria did not undergo
signiﬁcant changes. Conditions: MEC were incubated with HVTP (100 lM) and mitochondria were isolated at indicated time. After 4 h incubation cells were washed and then
were incubated in HVTP-free media. (C) Detection of NO generated in a model system containing a NO-donor, DEANONOate, using a speciﬁc probe mitoDAN (insert).
Conditions: DEANONOate 200 lM, mitoDAN 200 lM. Spectra a–d were recorded with a 1 min interval. (D) Time-course of accumulation of a ﬂuorescent product, triazole,
formed from mitoDAN after its interaction with NO released from HVTP in mitochondria in the presence of tBu-OOH. Conditions: Cells were incubated with mitoDAN
(100 lM) and HVTP (100 lM) for 1 h. After that mitochondria were isolated and treated with tBu-OOH (100 lM). Spectra were obtained immediately (a) 15 min (b), 30 min
(c) and 60 min (d) after addition of tBu-OOH. Insert – difference ﬂuorescence spectrum after subtraction from the spectrum (d) the initial spectrum (a). (E) and (F) Nitration of
cyt c in the course of peroxidase reaction of cyt c/TOCL complexes incubated in the presence of HVTP and H2O2. Effects of different concentrations of: (E) HVTP (2.5–12.5 mM);
(F) H2O2 (5–50 mM). Cyt c/CL ratio 0.2/2 mM, H2O2 5 mM (E), HVTP 12.5 mM (F).
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bated with MitoSOX (2.5 lM) in HBSS (with Ca2+/Mg2+) for 10 min.
Mean ﬂuorescence intensity of MitoSOX or DHE was acquired from
10 000 cells by FACScan ﬂow cytometer using a 585-nm bandpass
ﬁlter.
2.11. Membrane potential measurements
Mitochondrial membrane potential was determined by JC-1
staining. Brieﬂy, cells were stained with 10 lg/ml of JC-1 at 37 C
for 15 min and then washed twice with PBS. The samples were
analyzed immediately using RF-5301 PC spectroﬂuorimeter (exci-
tation 485 nm, slits 5 nm). The ratio of red (aggregates, 590 nm)
and green (monomer, 529 nm) ﬂuorescence was used as a relative
measure of mitochondrial membrane potential.
2.12. PS externalization
PS externalization was determined with an annexin V–FITC
apoptosis detection kit. Collected cells were resuspended in thebinding buffer and incubated with the annexin V–FITC conjugate
and propidium iodide for 5 min in the dark. Cell ﬂuorescence was
analyzed with a FACScan ﬂow cytometer with simultaneous moni-
toring of green ﬂuorescence for annexin V–FITC (530 nm, 30 nm
band-pass ﬁlter, FL-1) and red ﬂuorescence associated with propi-
dium iodide (long-pass emission ﬁlter that transmits >650 nm light,
FL-3). For each sample 10 000 events were recorded and analyzed.
2.13. Radiation survival curves
Cells were plated in 35 mm Petri dishes with 2 ml of culture
medium at a proper density (200–500 cells/dish). Cells were pre-
treated with HVTP for 4 h and then HVTP was removed from med-
ium right after irradiation. Colonies were ﬁxed and stained with
0.25% crystal violet and 10% formalin (35% vol/vol) in 80% metha-
nol for 30 min after a 5-day incubation period, and colonies of 50 or
more cells were counted as survivors. The surviving fractions were
calculated as the plating efﬁciency of samples relative to that of
control. Data were ﬁtted to the linear quadratic model by using
SigmaPlot 9.0 (Systat Software, San Jose, CA).
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Data are expressed as means ± S.D. or means ± S.E. where indi-
cated of at least triplicate determinations. Statistical comparisons
between groups were performed by using Student’s t-test. Differ-
ences were considered signiﬁcant at P < 0.05.
3. Results
3.1. HVTP integration and bioactivation in mitochondria
Incubation of MECs with HVTP (100 lM) lead to its accumula-
tion in mitochondria at the level of 30–40 pmol/lg protein as mea-
sured by HPLC. The amount of HVTP partitioned into mitochondria
within 1 h was maximal and did not change after 2, 4 and 24 h of
incubation (Fig. 1B). At this concentration of mitochondrial HVTP,
it did not induce toxicity (data not shown).
To examine the ability of HVTP to release NO upon activation of
peroxidase reactions in mitochondria we synthesized a speciﬁcFig. 2. Apoptotic markers of irradiation-induced cell death and protection with HVTP. (A
effect of HVTP pre-treatment (10–100 lM). Left panel – shown are typical Western bl
assessed at 24 h after irradiation using JC-1 ﬂuorescence measurements. (C) Caspase
generation in mitochondria (D) and whole (E) mouse embryonic cells in the presence an
irradiation. All data are presented as mean ± S.D. (n = 3–6). *P < 0.05 vs. irradiated cells wmitochondria-targeted ﬂuorescent probe diaminonaphthalene
conjugated with TP cation (mitoDAN, Fig. 1C, insert). Upon reaction
with NO mitoDAN is converted into a highly ﬂuorescent deriva-
tive, naphthotriazole with a characteristic ﬂuorescence spectra
(Fig. 1C; kex = 375 nm; kem = 433 nm). For quantiﬁcation of released
NO, we used 2-(N,N-diethylamino)-diazenolate 2-oxide (diethyl-
amine NONOate), which hydrolyses at 25 C with a half-life of
2 min to release 1.5 mol NO per mol of parent compound [11].
We pre-incubated MECs with HVTP (100 lM) and mitoDAN
(100 lM), then isolated mitochondria and assessed the content of
released NO by measuring ﬂuorescence of naphthotriazole. We
found that mitochondrial HVTP – upon incubation of cells with
tBu-OOH (100 lM) – gradually released NO, detected by mitoDAN
conversion into ﬂuorescent naphthotriazole (Fig. 1D). Notably the
resulting ﬂuorescence spectrum (Fig. 1D, insert with subtracted
background ﬂuorescence) was essentially identical to those ob-
tained in a simple model calibration system (Fig. 1C). These results
demonstrate targeted delivery of mitoDAN and HVTP in mitochon-
dria, and the ability of HVTP to release NO in the presence of) Cyt c release upon c-irradiation-induced apoptosis in MECs (at 48 h); shown is the
ots representative of three experiments. (B) Membrane potential of mitochondria
-3/7 activity (48 h after irradiation). (D) and (E) Irradiation induced superoxide
d absence of HVTP measured at 24 h. (F) PS externalization determined at 48 h after
ithout HVTP treatment.
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tBu-OOH.
Interactions of HVTP released NO with Tyr produced as inter-
mediates of peroxidase reaction of cyt c/CL complexes in the pres-
ence of H2O2 may yield nitrotyrosines [12]. Indeed, when cyt c/
TOCL was incubated with HVTP and H2O2, formation of nitrotyro-
sines on cyt c was observed using anti-nitrotyrosine antibody
(Fig. 1E and F). The effect was dependent on concentrations of both
HVTP and H2O2 (2.5–12.5 mM of HVTP and 5–50 mM of H2O2).
3.2. Protection against apoptosis
Next, we explored whether release of NO by HVTP was associ-
ated with its ability to protect MECs against irradiation induced
apoptosis. To this end, several end-points of apoptotic cell death
were investigated. Pretreatment of cells with HVTP (100 lM) for
4 h before c-irradiation, blocked release of cyt c from mitochondria
by approximately 50% (Fig. 2A). We assayed caspase-3/7 activity by
measuring accumulation of 7-amino-4-methylcoumarin (AMC), a
ﬂuorescent product of cleavage of DEVD–AMC. HVTP (100 lM)
inhibited irradiation induced caspase-3/7 activation by 40%
48 h after exposure to 10 Gy irradiation (Fig. 2C). The effect on cas-
pase-3/7 activity was independent of dithiothreitol treatment
(5 mM, data not shown) suggesting that the inhibition was not
due to formation of photolytically inactive S-nitrosocaspases. HVTP
also signiﬁcantly preserved mitochondrial membrane potential in
irradiated cells (Fig. 2B). Finally, PS externalization was also pre-
vented in HVTP-pretreated cells (Fig. 2F). The compound did not
display radiomitigating activity; only pretreatment before irradia-
tion was associated with protective effects (Fig. 2F). We found that
the increased production of superoxide in irradiated cells (24 h
after irradiation to a dose of 10 Gy) was quantitatively similar –
1.4–1.6 times – as detected by MitoSOX in mitochondria
(Fig. 2D) as well as by DHE in cells (Fig. 2E). In both cases, preincu-
bation of cells with HVTP did not prevent irradiation-induced
superoxide generation.
3.3. Clonogenic protection
Radioprotective effects of HVTP were further tested using the
clonogenic survival assay. Four hours treatment with HVTP exerted
no effect on the plating efﬁciency of MECs. Pretreatment (4 h) ofFig. 3. Clonogenic assay for c-irradiated MECs: (d) irradiated MECs; (s) irradiated
MECs after HVTP pretreatment (4 h, 100 lM). The surviving fractions were
calculated as the plating efﬁciency of the irradiated ± HVTP pretreated cells relative
to non-irradiated controls. Data are presented as mean ± S.E. (n = 6).cells with 100 lM HVTP provided marked protection (Fig. 3). Sur-
viving curves were ﬁtted with linear quadratic model. Low-dose ef-
fect was insigniﬁcant (a = 0.129 ± 0.016 for irradiated cells vs.
0.117 ± 0.006 for HVTP pretreated and irradiated cells). However
at higher doses, the protection was signiﬁcant (b = 0.016 ± 0.003
vs. 0.007 ± 0.001 for irradiated cells and HVTP pretreated and irra-
diated cells, respectively, P < 0.01).4. Discussion
This work reports, for the ﬁrst time, the protective effect of
mitochondria-targeted compound, HVTP – acting as a donor of
NO activated by the peroxidase function of cyt c/CL complexes –
against irradiation-induced apoptosis in MECs. Using a mitochon-
dria-targeted NO-speciﬁc ﬂuorescent probe, mitoDAN, we showed
that in mitochondria isolated from MECs, NO was indeed released
by the intrinsic peroxidase activity triggered by exposure of mito-
chondria to tBu-OOH. We performed assessments of HVTP integra-
tion into cells and found that after 30 min incubation of HVTP with
MECs, a substantial amount of the donor (about 90 ± 2% from its
initial concentration) was still present in the incubation medium,
while only 10% of its content was integrated into cells. However,
no detectable HVTP was present in the cytosolic fraction of cells
as evidenced by experiments with cell fractionation [8]. Using
HPLC measurements, we determined that accumulation of HVTP
in mitochondria was at the level of 30–40 pmol/lg protein. These
results indicate that the entire amount of HVTP incorporated into
cells was targeted exclusively to the mitochondria.
Previous work demonstrated that peroxidase activity of cyt c/CL
complexes facilitates CL oxidation that plays crucial role in apopto-
sis by stimulating the release of pro-apoptotic factors from mito-
chondria into the cytosol [13]. Because this CL oxidizing effect of
cyt c/CL complexes takes place early during the execution of apop-
totic program in mitochondria before, blocking the peroxidase
activity may be protective against irreversible stages of apoptosis
associated with the activation of caspases. Our previous studies
demonstrated successful prevention of apoptotic cell death by
mitochondria-targeted nitroxides capable of scavenging electrons
from disrupted electron transport chains [5,14] hence eliminating
H2O2 required to feed the peroxidase cycle of cyt c/CL complexes.
Alternative approaches can be based on direct inhibition of the
peroxidase activity. NO has been reported as effective quencher of
reactive intermediates of cyt c/CL peroxidase complex and CL per-
oxidation [12]. In this paradigm, NO is expected to exert anti-
apoptotic effect [8,15]. The speciﬁc activation of HVTP by the per-
oxidase activity of cyt c/CL complexes may be particularly impor-
tant in providing molecular proximity of NO to the essential site
of its required inhibitory action – active site of the peroxidase com-
plexes. Our results demonstrating nitration of tyrosine residues in
cyt c/CL complexes suggest that nitration of catalytically compe-
tent Tyr residues may be responsible, at least in part, for the
HVTP-dependent inhibition of the peroxidase activity of cyt c/CL
complexes. In line with this interpretation, we found that HVTP in-
deed was able to effectively inhibit irradiation induced apoptosis in
MECs as evidenced by its ability to prevent accumulation of several
characteristic biomarkers. The fact that HVTP attenuated cyt c re-
lease and mitochondrial membrane permeabilization indicated
that the site of its action was upstream of caspase activation.
Therefore, the ability of HVTP to prevent caspase-3/7 activation
and PS externalization was not surprising.
Interestingly, HVTP did not affect irradiation induced produc-
tion of ROS by disrupted electron transport. It is well known that
NO avidly reacts with superoxide to yield peroxynitrite [16]. Be-
cause this reaction competes with the detection of O2 by DHE,
one would expect that release of NO by HVTP should be accompa-
1950 N.A. Belikova et al. / FEBS Letters 583 (2009) 1945–1950nied by apparent decrease of detectable superoxide. The absence of
this effect may be interpretable in terms of molecular proximity of
HVTP-driven release of NO to the catalytic site of the peroxidase
complex and its effective consumption by the reactive peroxidase
intermediates.
In addition to effectively suppressing apoptotic cell death, HVTP
exerted its protective action on proliferative activity of MECs as
evidenced by increased colony-formation capability after exposure
to high doses of irradiation (>5 Gy). Thus it is possible that HVTP
realized its radioprotective action, at least in part, via enhanced
DNA repair. Speciﬁc mechanisms underlying these radioprotective
properties of HVTP need further studies.
In conclusion, mitochondria-targeted pro-drugs bioactivatable
by peroxidase activity of cyt c/CL complexes to NO-donors repre-
sent a new interesting class of anti-apoptotic radioprotectors.
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